Literature DB >> 22315279

Epidemiologic consequences of microvariation in Mycobacterium tuberculosis.

Barun Mathema1, Natalia Kurepina, Guibin Yang, Elena Shashkina, Claudia Manca, Carolina Mehaffy, Helle Bielefeldt-Ohmann, Shama Ahuja, Dorothy A Fallows, Angelo Izzo, Pablo Bifani, Karen Dobos, Gilla Kaplan, Barry N Kreiswirth.   

Abstract

BACKGROUND: Evidence from genotype-phenotype studies suggests that genetic diversity in pathogens have clinically relevant manifestations that can impact outcome of infection and epidemiologic success. We studied 5 closely related Mycobacterium tuberculosis strains that collectively caused extensive disease (n = 862), particularly among US-born tuberculosis patients.
METHODS: Representative isolates were selected using population-based genotyping data from New York City and New Jersey. Growth and cytokine/chemokine response were measured in infected human monocytes. Survival was determined in aerosol-infected guinea pigs.
RESULTS: Multiple genotyping methods and phylogenetically informative synonymous single nucleotide polymorphisms showed that all strains were related by descent. In axenic culture, all strains grew similarly. However, infection of monocytes revealed 2 growth phenotypes, slower (doubling ∼55 hours) and faster (∼25 hours). The faster growing strains elicited more tumor necrosis factor α and interleukin 1β than the slower growing strains, even after heat killing, and caused accelerated death of infected guinea pigs (∼9 weeks vs 24 weeks) associated with increased lung inflammation/pathology. Epidemiologically, the faster growing strains were associated with human immunodeficiency virus and more limited in spread, possibly related to their inherent ability to induce a strong protective innate immune response in immune competent hosts.
CONCLUSIONS: Natural variation, with detectable phenotypic changes, among closely related clinical isolates of M. tuberculosis may alter epidemiologic patterns in human populations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22315279      PMCID: PMC3415951          DOI: 10.1093/infdis/jir876

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  50 in total

1.  Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination.

Authors:  S Sreevatsan; X Pan; K E Stockbauer; N D Connell; B N Kreiswirth; T S Whittam; J M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology.

Authors:  J D van Embden; M D Cave; J T Crawford; J W Dale; K D Eisenach; B Gicquel; P Hermans; C Martin; R McAdam; T M Shinnick
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

3.  Widespread dissemination of a drug-susceptible strain of Mycobacterium tuberculosis.

Authors:  C R Friedman; G C Quinn; B N Kreiswirth; D C Perlman; N Salomon; N Schluger; M Lutfey; J Berger; N Poltoratskaia; L W Riley
Journal:  J Infect Dis       Date:  1997-08       Impact factor: 5.226

4.  Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology.

Authors:  J Kamerbeek; L Schouls; A Kolk; M van Agterveld; D van Soolingen; S Kuijper; A Bunschoten; H Molhuizen; R Shaw; M Goyal; J van Embden
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

5.  A new evolutionary scenario for the Mycobacterium tuberculosis complex.

Authors:  R Brosch; S V Gordon; M Marmiesse; P Brodin; C Buchrieser; K Eiglmeier; T Garnier; C Gutierrez; G Hewinson; K Kremer; L M Parsons; A S Pym; S Samper; D van Soolingen; S T Cole
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

6.  Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model.

Authors:  J Dormans; M Burger; D Aguilar; R Hernandez-Pando; K Kremer; P Roholl; S M Arend; D van Soolingen
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

7.  A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response.

Authors:  Michael B Reed; Pilar Domenech; Claudia Manca; Hua Su; Amy K Barczak; Barry N Kreiswirth; Gilla Kaplan; Clifton E Barry
Journal:  Nature       Date:  2004-09-02       Impact factor: 49.962

8.  Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains.

Authors:  R D Fleischmann; D Alland; J A Eisen; L Carpenter; O White; J Peterson; R DeBoy; R Dodson; M Gwinn; D Haft; E Hickey; J F Kolonay; W C Nelson; L A Umayam; M Ermolaeva; S L Salzberg; A Delcher; T Utterback; J Weidman; H Khouri; J Gill; A Mikula; W Bishai; W R Jacobs; J C Venter; C M Fraser
Journal:  J Bacteriol       Date:  2002-10       Impact factor: 3.490

9.  Mycobacterial virulence. Virulent strains of Mycobacteria tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity.

Authors:  R J North; A A Izzo
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

10.  Recognition and destruction of Bacillus Calmette-Guerin-infected human monocytes.

Authors:  A Molloy; P A Meyn; K D Smith; G Kaplan
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

View more
  13 in total

1.  Characterization of Mutations Conferring Resistance to Rifampin in Mycobacterium tuberculosis Clinical Strains.

Authors:  Tomasz Jagielski; Zofia Bakuła; Anna Brzostek; Alina Minias; Radosław Stachowiak; Joanna Kalita; Agnieszka Napiórkowska; Ewa Augustynowicz-Kopeć; Anna Żaczek; Edita Vasiliauskiene; Jacek Bielecki; Jarosław Dziadek
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

Review 2.  Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria.

Authors:  Tomasz Jagielski; Alina Minias; Jakko van Ingen; Nalin Rastogi; Anna Brzostek; Anna Żaczek; Jarosław Dziadek
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

3.  Factors affecting tuberculosis strain success over 10 years in a high TB- and HIV-burdened community.

Authors:  Keren Middelkoop; Linda-Gail Bekker; Barun Mathema; Landon Myer; Elena Shashkina; Andrew Whitelaw; Natalia Kurepina; Gilla Kaplan; Barry Kreiswirth; Robin Wood
Journal:  Int J Epidemiol       Date:  2014-03-07       Impact factor: 7.196

4.  Large-scale whole genome sequencing of M. tuberculosis provides insights into transmission in a high prevalence area.

Authors:  J A Guerra-Assunção; A C Crampin; R M G J Houben; T Mzembe; K Mallard; F Coll; P Khan; L Banda; A Chiwaya; R P A Pereira; R McNerney; P E M Fine; J Parkhill; T G Clark; J R Glynn
Journal:  Elife       Date:  2015-03-03       Impact factor: 8.140

5.  Importance of cough and M. tuberculosis strain type as risks for increased transmission within households.

Authors:  Edward C Jones-López; Soyeon Kim; Geisa Fregona; Patricia Marques-Rodrigues; David Jamil Hadad; Lucilia Pereira Dutra Molina; Solange Vinhas; Nancy Reilly; Stephanie Moine; Soumitesh Chakravorty; Mary Gaeddert; Rodrigo Ribeiro-Rodrigues; Padmini Salgame; Moises Palaci; David Alland; Jerrold J Ellner; Reynaldo Dietze
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

6.  Genomic epidemiology of Lineage 4 Mycobacterium tuberculosis subpopulations in New York City and New Jersey, 1999-2009.

Authors:  Tyler S Brown; Apurva Narechania; John R Walker; Paul J Planet; Pablo J Bifani; Sergios-Orestis Kolokotronis; Barry N Kreiswirth; Barun Mathema
Journal:  BMC Genomics       Date:  2016-11-21       Impact factor: 3.969

7.  Whole genome sequencing versus traditional genotyping for investigation of a Mycobacterium tuberculosis outbreak: a longitudinal molecular epidemiological study.

Authors:  Andreas Roetzer; Roland Diel; Thomas A Kohl; Christian Rückert; Ulrich Nübel; Jochen Blom; Thierry Wirth; Sebastian Jaenicke; Sieglinde Schuback; Sabine Rüsch-Gerdes; Philip Supply; Jörn Kalinowski; Stefan Niemann
Journal:  PLoS Med       Date:  2013-02-12       Impact factor: 11.069

8.  Population structure among mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Colombia.

Authors:  Teresa Realpe; Nidia Correa; Juan Carlos Rozo; Beatriz Eugenia Ferro; Beatriz Elena Ferro; Verónica Gomez; Elsa Zapata; Wellman Ribon; Gloria Puerto; Claudia Castro; Luisa María Nieto; Maria Lilia Diaz; Oriana Rivera; David Couvin; Nalin Rastogi; Maria Patricia Arbelaez; Jaime Robledo
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

9.  Long-term dominance of Mycobacterium tuberculosis Uganda family in peri-urban Kampala-Uganda is not associated with cavitary disease.

Authors:  Eddie M Wampande; Ezekiel Mupere; Sara M Debanne; Benon B Asiimwe; Mary Nsereko; Harriet Mayanja; Kathleen Eisenach; Gilla Kaplan; Henry W Boom; Sebastien Gagneux; Moses L Joloba
Journal:  BMC Infect Dis       Date:  2013-10-17       Impact factor: 3.090

10.  Whole genome sequencing identifies circulating Beijing-lineage Mycobacterium tuberculosis strains in Guatemala and an associated urban outbreak.

Authors:  Joseph W Saelens; Dalia Lau-Bonilla; Anneliese Moller; Narda Medina; Brenda Guzmán; Maylena Calderón; Raúl Herrera; Dana M Sisk; Ana M Xet-Mull; Jason E Stout; Eduardo Arathoon; Blanca Samayoa; David M Tobin
Journal:  Tuberculosis (Edinb)       Date:  2015-09-28       Impact factor: 3.131

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.